Loading news article.

Newsbenzinga

Eli Lilly Mounjaro Clocks 65% Jump in Sales to Massive $10.7 billion

Oct 29, 2026, 09:53 ET · Published

Article summary

Eli Lilly tops Q3 forecasts on surging Mounjaro sales, raises 2026 revenue outlook to $92 billion, and hits new 52-week highs despite an EPS forecast trim.

An excerpt from the original article.

Related companies

LLYLLYView stock

Repost

Comments —

Loading comments…